Mass.-based iRobot to lay off 31% of staff as Amazon calls off bid to buy amid pushback in Europe
https://www.boston.com/news/business/2024/01/29/amazon-calls-off-bid-to-buy-mass-based-irobot-amid-scrutiny-in-the-u-s-and-europe/
Jan 29, 2024 -
The CEO will also step down.
The post Mass.-based iRobot to lay off 31% of staff as Amazon calls off bid to buy amid pushback in Europe appeared first on Boston.com.
0
Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)
https://seekingalpha.com/news/4054495-amgen-may-be-evaluating-cytokinetics-bid-cytk-wants-130-145-a-share-report?source=feed_sector_healthcare
Jan 11, 2024 - Novartis backs away from Cytokinetics deal, leaving room for speculation that Amgen may be interested in acquiring the biotech firm.
0
Greenback Is Bid Ahead Of The Jobs Report
https://seekingalpha.com/article/4661319-greenback-is-bid-ahead-of-the-jobs-report?source=feed_tag_forex
Jan 05, 2024 - Stocks have been hit by profit-taking to start this year, but Gold is trading heavier. Click here to read more about world currency trends.
0
U.S. judge upholds FTC bid to block Iqvia’s DeepIntent buyout
https://seekingalpha.com/news/4051702-iqvia-stock-slips-legal-setback-deepintent-deal?source=feed_sector_healthcare
Jan 02, 2024 - Iqvia Holdings (IQV) faces setback in acquisition of DeepIntent after U.S. court upholds FTC's order to block the deal over antitrust concerns. Read more here.
0
Weekend Reading - Another Good Labor Report; Commodities Can't Catch A Bid
https://seekingalpha.com/article/4657133-weekend-reading-another-good-labor-report-commodities-cant-catch-bid?source=feed_all_articles
Dec 10, 2023 - The employment report showed another solid gain. The underlying data remained a bit mixed, but on the whole the job gains were broad and consistent with reasonably strong aggregate demand.
0
Microbix announces initiation of normal course issuer bid
https://seekingalpha.com/news/4044038-microbix-announces-initiation-of-normal-course-issuer-bid?source=feed_sector_healthcare
Dec 06, 2023 - Microbix Biosystems announces a Normal Course Issuer Bid program to repurchase and cancel outstanding shares.
0